Global Candidiasis Treatment Market: Overview

Candida yeasts generally live within the intestinal tract, and they are also found on mucous membranes and the skin. Candidiasis is a fungal infection caused by Candida sp. yeasts. There are more than 20 species of Candida sp. that can cause infections in humans. Symptoms of candidiasis include itching, irritation, burning sensation, redness, swelling, pain, soreness, and rash. They depend on the infected area of the body. The diagnosis of candidiasis depends on the medical history of the patient, symptoms, physical investigations, laboratory examinations, and others. Mostly, health care practitioners diagnose candidiasis by investigating the culture of blood tests in laboratories. When laboratory tests find growth of Candida yeasts in the cultured blood, medical practitioners treat candidiasis by prescribing a specific dose of antifungal medications. However, the treatment of candidiasis depend on the age of patients, symptoms, medical history, immunity status, location of the infections, etc.

Global Candidiasis Treatment Market: Key Trends

The global candidiasis treatment market is primarily driven by a rise in the cases of candidiasis worldwide and high rate of diagnosis and treatment of candidiasis. However, side effects of antifungal medications, product recalls, stringent regulatory conditions, etc. are anticipated to hamper the growth of the global candidiasis treatment market in the near future. Nevertheless, an increase in research and development expenditure by major players, strategic alliances by companies, and strong product pipeline are projected to provide attractive opportunities to the global candidiasis treatment market during the forecast period.     

Global Candidiasis Treatment Market: Segmentation

The global candidiasis treatment market can be segmented in terms of candidiasis, route of administration, distribution channel, and geography. In terms of candidiasis, the global candidiasis treatment market can be classified into vaginal candidiasis, invasive candidiasis, and esophagus candidiasis. Based on route of administration, the global candidiasis treatment market can be categorized into oral, parenteral, and topical. In terms of distribution channel, the global candidiasis treatment market can be segmented into hospital pharmacies, retail pharmacies and drug stores, and online sales.

Global Candidiasis Treatment Market: Regional Analysis

Based on geography, the global candidiasis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the CDC, invasive candidiasis is a common type of health care-associated infection. Around 50,000 cases of invasive candidiasis are estimated to occur annually in the U.S. Candidemia, which is the most predominant form of invasive candidiasis, occurs in 10 to 14 individuals per 100,000 per year in the U.S. The candidiasis treatment market in North America held a prominent market share in 2017, owing to a significant number of cases of candidiasis, strong diagnosis and treatment rate of candidiasis, and robust health care infrastructure in the region.

A study published in the Journal of Fungi in 2017 showed that invasive candidiasis occurred in almost 5 individuals per 100,000 per year in the U.K. In Spain, the incidence of invasive candidiasis was estimated at almost 6 to 7 cases per 100,000 per year, whereas the incidence was found to be higher in Eastern Europe. The candidiasis treatment market in Europe constituted a prominent market share in 2017, due to a high incidence of candidiasis, strong health care infrastructure, and advanced medical research.

The candidiasis treatment market in Asia Pacific is anticipated to expand at a high growth rate during the forecast period, owing to a rise in the population, developing health care infrastructure, presence of domestic companies, and competition between major companies and domestic companies. However, low awareness about hygiene and weak medical infrastructure are likely to restrain the growth of the candidiasis treatment market in Latin America and Middle East & Africa during the forecast period.

Global Candidiasis Treatment Market: Competitive Landscape

Key companies operating in the global candidiasis treatment market are Bayer, Teva Pharmaceuticals, Pfizer, Glenmark Pharmaceuticals, Ranbaxy, and others.

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Candidiasis Treatment Market